You know that feeling when you look at a promising stock and ask yourself, “Is this the next big thing that will send me into early retirement, or a spectacular belly landing?” That’s exactly where we are right now at Hydreight Technologies in August 2026. The telemedicine sector is currently an absolute shark tank. While the competition is whining about falling margins and a brutal price war, Hydreight simply achieved 449% sales growth in the first quarter. But on the stock market, yesterday’s success is already cold coffee today. The upcoming Q2 figures, probably this week, will be the ultimate stress test. And in the background? There sits Victory Square Technologies (VST) and rubs its hands in the face of an ingenious contract clause.Thanks for reading! Subscribe for free to receive new posts and support my work.The 449 percent shock and the awakening of the competitionLet’s put the facts on the table for a moment: In the first quarter of 2026, Hydreight virtually pulverized all expectations. Revenue jumped to $24.9 million (up 449% year-over-year), and adjusted EBITDA shot up over 1,400% to $3.3 million. The management was so confident that it cemented the annual guidance at a whopping USD 150 million.But now it gets tricky. The overall market for telemedicine and weight loss drugs (GLP-1) is cooling down massively. Big fish such as Hims & Hers or LifeMD presented their Q2 figures in August and absolutely disappointed the market. The episode? Massive crashes because the price war eats away at gross margins.“The upcoming second quarter must now prove that this level is sustainable, especially since the strong competition in the telemedicine sector has recently revealed massive margin problems.”Why this point is so crucial: This market environment makes Hydreight’s Q2 report an absolute showdown. If the entire sector weakens, but Hydreight continues to deliver such growth with stable profitability (the targeted 15% to 17% EBITDA margin), this signals a certain “pricing power” to the market. It shows that Hydreight’s B2B approach is more robust than the competition’s error-prone end-user (D2C) model.The Anatomy of a Record Quarter – What Q1 Told UsTo understand what we can expect in Q2, we need to look at the machine under the hood. Hydreight not only earned brilliantly in the first quarter, but also ended the quarter with CAD 24.2 million in cash and CAD 32.0 million in working capital. That’s a gigantic cushion for a micro-cap player.However, there is also a small warning: the gross margin fell from 33% to about 20.4%. This is a clear sign that the sales mix is shifting.Why this is so crucial: The decline in gross margin may seem like an alarm signal at first glance, but it illustrates the true business model: volume. As long as Hydreight can keep fixed costs extremely low due to this massive volume (operating costs fell to only 9% of sales in Q1), the so-called “operating leverage” will apply. This means that every additional dollar earned has a disproportionately strong impact on pure profit (EBITDA).VSDHOne – The Actual Brain of the SurgeryThe real star of the show is not the single nurse who gives an IV IV, but the platform behind it: VSDHOne. This plug-and-play digital infrastructure gives healthcare brands instant access to a nationwide network in all 50 U.S. states.By August 2026, licenses sold had exploded from around 3,000 at the end of 2025 to an incredible 12,000+. In addition, there are over 300 doctors and more than 3,000 nurses who support this network.Why this point is so crucial: The 12,000 licenses are a massive leading indicator. A sold license is not yet immediate revenue, but it represents the future transaction volume. The network is now large enough to handle even the largest national health campaigns. Anyone who owns this “rail network” of telemedicine collects money on every single train journey.Victory Square Technologies (VST) – The Laughing Puppeteer in the BackgroundNow it gets really exciting for investors. Victory Square Technologies (VST) not only holds around 44.5% of the shares in Hydreight (Value: approximately 98 million CAN$, market capitalization: approximately 66 million CAN$), but has also secured a contractual goldmine when it was founded: a direct “profit share” of 10% on the VSDHOne platform.And here is the crucial difference that is often misunderstood: It is not a revenue share, but a profit share. VST receives 10% of the money left over after deducting all of the platform’s direct operating costs. Historically, Hydreight had waived all payments to VST until the end of 2025, but since Q1 2026, the clock has been ticking – and the first provisions ($192,000) have already been recognized.Why this point is so crucial: This clause is a masterpiece of corporate structuring. VST has thus secured a completely market-independent cash flow. Whether Hydreight’s share price falls or rises by 20% tomorrow – as long as the platform generates an operating profit, hard money will flow into VST’s coffers. It is the ultimate in enterprise-level passive income.The Magic Table – When Economies of Scale Really Bang (2026-2030)Let’s play with the numbers a bit. Analysts believe that Hydreight can maintain annual revenue growth of a whopping 60.2% through its scaling and could even crack the $1 billion mark in the medium term. At the same time, we assume that the efficiency of the platform will increase the profit margin from a conservative 15% in 2026 to 25% in 2030. Revenue and margin will then look like this:How does this affect VST’s 10% profit share?These mind-blowing numbers are: Look at operating leverage: Revenue doesn’t even increase tenfold in this model (it increases by about 6.6 by a factor), but the annual payout to VST increases elevenfold from $2.25 million to nearly $25 million. Over the entire 5-year period, VST would cumulatively pocket around $52.7 million in cash flow – and that’s just from this one contractual clause, mind you, completely independent of the value of their 44.5% share package!The reality check – Where are the stumbling blocks for Q2?The upcoming quarterly figures are no walk in the park. To achieve its annual guidance of $150 million, Hydreight needs to turn over an average of nearly $42 million per quarter in the three quarters (Q2 to Q4).In addition, the company is diluting its share base. Due to a CAD 15 million financing in January and outstanding convertible bonds, there is a moderate to high dilution risk. Although management has announced a share buyback program (NCIB) for up to 9.3% of the shares, mere permission to buy back does not mean that the shares will actually be bought.Why this point is so crucial: A “beat” (exceeding expectations) is extremely likely, as the prior-year quarter (Q2 2025) was extremely weak operationally with only CAD 5.38 million in GAAP revenue and tiny profits. So the percentage growth rates will look astronomical again. However, the smart money does not look at the previous year, but at the comparison to Q1 2026. And more importantly, will the EBITDA margin remain stable?The final conclusionHydreight Technologies is sitting on an absolute gold vein if the company succeeds in continuing to establish its VSDHOne platform as the industry-wide standard for telemedicine infrastructure. The upcoming Q2 will show us unequivocally whether the company is building a true “pricing power” monopoly, to the great delight of Victory Square Technologies. or just surf along on the short-term hype wave of weight loss injections.What do you think about the stock? Thanks for reading! This post is public so feel free to share it.ShareMy wikifolios PPinvest Low Vola and PPinvest AI system have a combined AUM of over 15 Mio. Euro and are both in the Top 10 ranked, out of > 30.000 wikifolios.My investment style is a mixture of value/momentum investor. Based on the fundamental data (VALUE) and the price development of the last 52 weeks (MOMENTUM), the stock is currently one of my TOP stocks. These are the stocks where I see the highest chances of strong price gains in the medium term (1-3 years). I also buy these values in my wikifolios and at FollowMyMoney.Subscribe nowMy stock ideas are part of the “Elite Investor Feed” at ☛ YellobrickELITE INVESTORS are the top 5% of investors, in a database of over 3,000 investors.The performance of my stock ideas is tracked, independently of me. At the moment, it looks like this.“Speculative investments are like a tennis match: the decisive factor is to concentrate fully on the next ace instead of being annoyed by the last double fault.” A. GerstenbergerDisclaimerThis text was partly created with AI applications.All content is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell securities or other financial market instruments. Of course, I try to present the facts to the best of my knowledge and belief, but they can still be false in whole or in part.Therefore, I do not accept any liability for investment decisions that you make on the basis of the information presented here.Conflict of interest: At the time of publication, the author of this publication holds shares/securities of the securities/companies discussed here and intends to sell them depending on the market situation and could benefit in particular from increased trading liquidity. As a result, there is a concrete and clear conflict of interest.